Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.336ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.336ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.336ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.336NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.400.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.400.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.400.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.400.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.537ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.537ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.537ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.537NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.548ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.548ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.548ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.548NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.24.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.24.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.24.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.24.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.492ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.492ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.492ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.492NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.540ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.540ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.540ENiu-ECACGTTAACAATATTGCAGC20402639126372R-18330.5China
B.1.540NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.487ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.487ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.487ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.487NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.118ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.118ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.118ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.118NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.357ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.357ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.357ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.357NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used